skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A general chemical principle for creating closure-stabilizing integrin inhibitors

Journal Article · · Cell

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1901102
Journal Information:
Cell, Vol. 185, Issue (19)
Country of Publication:
United States
Language:
ENGLISH

References (83)

Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis journal January 2020
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
UR-3216: A New Generation Oral Platelet GPIIb / IIIa Antagonist journal May 2004
Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. journal August 1989
Regulation of integrin α5β1 conformational states and intrinsic affinities by metal ions and the ADMIDAS journal May 2022
Structural mechanism of laminin recognition by integrin journal June 2021
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial journal March 1999
UR-3216: A Manageable Oral GPIIb/IIIa Antagonist journal June 2006
Delayed tirofiban-induced thrombocytopenia: two case reports journal May 2005
Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin journal June 2012
Identification and characterization of antibodies that bind GPIIb/IIIa: Antagonist complexes journal June 2005
Anti-integrin monoclonal antibodies journal November 2009
Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β journal February 2020
Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists journal January 2001
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist journal January 2005
Pentamidine Is a Specific, Non-Peptide, GPIIb/llla Antagonist journal January 1996
Integrins as therapeutic targets: lessons and opportunities journal October 2010
Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes journal November 2000
Platelet Activation and Atherothrombosis journal December 2007
Differential Antiplatelet Effects of Various Glycoprotein IIb–IIIa Antagonists journal January 2001
Structural determinants of integrin β-subunit specificity for latent TGF-β journal November 2014
Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino methyl)phenyl]-1-piperazinyl]-1- piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent journal November 1994
Features and development of Coot journal March 2010
Intact α IIb β 3 Integrin Is Extended after Activation as Measured by Solution X-ray Scattering and Electron Microscopy journal August 2011
Platelet Activation in Unstable Coronary Disease journal October 1986
Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. journal April 1990
Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. journal September 1988
New peptidomimetics in the chemistry of fibrinogen receptor antagonists journal January 1995
New antithrombotic RGD-mimetics with high bioavailability journal October 1996
Clot Retraction: Cellular Mechanisms and Inhibitors, Measuring Methods, and Clinical Implications journal August 2021
XDS journal January 2010
Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. journal September 1991
First Human Use of RUC‐4: A Nonactivating Second‐Generation Small‐Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point‐of‐Care Treatment of ST‐Segment–Elevation Myocardial Infarction journal September 2020
A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1. journal October 1993
Integrin-based therapeutics: biological basis, clinical use and new drugs journal January 2016
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations journal August 2019
Integrin extension enables ultrasensitive regulation by cytoskeletal force journal April 2017
Energy landscape differences among integrins establish the framework for understanding activation journal November 2017
Conformational equilibria and intrinsic affinities define integrin activation journal January 2017
RUC-4: A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction journal October 2014
Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand journal February 2003
A Specific Interface between Integrin Transmembrane Helices and Affinity for Ligand journal June 2004
Activated Conformations of Very Late Activation Integrins Detected by a Group of Antibodies (HUTS) Specific for a Novel Regulatory Region(355-425) of the Common β1 Chain journal May 1996
CuI-Catalyzed Coupling Reaction of β-Amino Acids or Esters with Aryl Halides at Temperature Lower Than That Employed in the Normal Ullmann Reaction. Facile Synthesis of SB-214857 journal July 2001
Effect of GR144053, a Fibrinogen-Receptor Antagonist, on Thrombus Formation and Vascular Patency After Thrombolysis by tPA in the Injured Carotid Artery of the Hamster journal August 1998
GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster journal November 1997
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial journal February 2012
An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice journal August 1995
Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture. journal November 1992
Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit journal April 1995
A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients journal April 2001
Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men journal August 1997
Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist journal November 2009
Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor journal March 2012
Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3 journal January 1985
Physiological Models Are Good Tools to Predict Rat Bioavailability of EF5154 Prodrugs from In Vitro Intestinal Parameters journal April 2009
Delayed profound thrombocytopenia associated with eptifibatide journal December 2006
Intrinsic Activating Properties of GP IIb/IIIa Blockers journal September 2001
Safety, Tolerability, Pharmacokinetics, and Time Course of Pharmacologic Response of the Active Metabolite of Roxifiban, XV459, a Glycoprotein IIb/IIIa Antagonist, following Oral Administration in Healthy Volunteers journal July 2002
Genome engineering using the CRISPR-Cas9 system journal October 2013
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors journal March 2009
Platelet Glycoprotein IIb-IIIa Antagonists as Prototypical Integrin Blockers:  Novel Parenteral and Potential Oral Antithrombotic Agents journal August 2000
Structural insights into integrin α 5 β 1 opening by fibronectin ligand journal May 2021
An internal ligand-bound, metastable state of a leukocyte integrin, α X β 2 journal November 2013
Therapeutic antagonists and conformational regulation of integrin function journal September 2003
Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling journal September 2002
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists journal February 2013
Platelet GPIIb-IIIa blockers journal January 1999
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease journal July 2003
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction journal May 1990
General structural features that regulate integrin affinity revealed by atypical αVβ8 journal December 2019
Orally Active Fibrinogen Receptor Antagonists. 2. Amidoximes as Prodrugs of Amidines journal January 1996
Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers journal May 1999
"Panning" for lymphocytes: a method for cell selection. journal June 1978
Metal ion and ligand binding of integrin α 5 β 1 journal December 2014
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics journal September 2004
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand journal March 2002
How Natalizumab Binds and Antagonizes α 4 Integrins journal September 2013
Structural specializations of α 4 β 7 , an integrin that mediates rolling adhesion journal January 2012
The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist journal April 1997
Structure-Guided Design of a High-Affinity Platelet Integrin  IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS journal March 2012
Complete integrin headpiece opening in eight steps journal June 2013
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening journal December 2010

Similar Records

The Use of Inhibitors for Controlling Metal Corrosion. Part I. General Principles
Journal Article · 1948 · Metallurgia (England) Published August 1971 - December 1977 as Metall. Met. Form. · OSTI ID:1901102

A novel integrin {alpha}5{beta}1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor
Journal Article · 2008 · Biochemical and Biophysical Research Communications · OSTI ID:1901102

Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor
Journal Article · 1994 · Radiation Research · OSTI ID:1901102

Related Subjects